1 week Ago By Defense World Staff
Legal & General Group Plc grew its position in Clover Health Investments, Corp. ( NASDAQ:CLOV – Free Report ) by 24.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission.
The institutional investor owned 345,086 shares of the company’s stock after purchasing an additional 68,256 shares during the quarter. Legal & General Group Plc owned approximately 0.07% of Clover Health Investments worth $1,087,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Steph & Co. grew its position in Clover Health Investments by 33.
3% during the 4th quarter. Steph & Co. now owns 20,000 shares of the company’s stock worth $63,000 after purchasing an additional 5,000 shares during the last quarter.
Arizona State Retirement System boosted its stake in shares of Clover Health Investments by 6.3% during the 4th quarter. Arizona State Retirement System now owns 118,265 shares of the company’s stock worth $373,000 after acquiring an additional 6,990 shares in the last quarter.
SignalPoint Asset Management LLC increased its stake in Clover Health Investments by 6.2% in the 4th quarter. SignalPoint Asset Management LLC now owns 160,074 shares of the company’s stock valued at $504,000 after purchasing an additional 9,390 shares in the last quarter.
ADAR1 Capital Management LLC purchased a new position in Clover Health Investments in the 4th quarter valued at approximately $73,000. Finally, Thoroughbred Financial Services LLC purchased a new position in Clover Health Investments in the 4th quarter valued at approximately $84,000. 19.
77% of the stock is currently owned by institutional investors and hedge funds. Analyst Ratings Changes Separately, Canaccord Genuity Group raised their price target on Clover Health Investments from $4.20 to $4.
50 and gave the stock a “buy” rating in a research report on Monday, March 3rd. Insider Activity In related news, General Counsel Karen Soares sold 52,500 shares of Clover Health Investments stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $3.
80, for a total value of $199,500.00. Following the transaction, the general counsel now owns 1,299,663 shares in the company, valued at approximately $4,938,719.
40. This trade represents a 3.88 % decrease in their ownership of the stock.
The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website . Also, Director Carladenise Armbrister Edwards sold 200,000 shares of the business’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $3.
61, for a total value of $722,000.00. Following the transaction, the director now owns 273,227 shares in the company, valued at approximately $986,349.
47. This represents a 42.26 % decrease in their position.
The disclosure for this sale can be found here . Insiders sold a total of 327,500 shares of company stock valued at $1,197,500 over the last quarter. Company insiders own 22.
28% of the company’s stock. Clover Health Investments Stock Down 1.2 % Shares of NASDAQ:CLOV opened at $3.
43 on Monday. The company has a market cap of $1.75 billion, a P/E ratio of -17.
15 and a beta of 1.98. Clover Health Investments, Corp.
has a 52 week low of $0.63 and a 52 week high of $4.87.
The business has a fifty day simple moving average of $3.71 and a 200-day simple moving average of $3.75.
Clover Health Investments Company Profile ( Free Report ) Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance.
It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. See Also Five stocks we like better than Clover Health Investments Ride Out The Recession With These Dividend Kings Texas Instruments: Earnings Beat, Upbeat Guidance Fuel Recovery Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed O’Reilly Automotive: An Anytime Buy for Buy-and-Hold Investors 5 discounted opportunities for dividend growth investors Chipotle Mexican Grill Serves Smoking Hot Entry Point in Q2 Want to see what other hedge funds are holding CLOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clover Health Investments, Corp.
( NASDAQ:CLOV – Free Report ). Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter .
.
